|
Ado-trastuzumab (T) emtansine (T-DM1) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Kadcyla
Chicago, Illinois1 trial
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
University of Chicago
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.